Case Report | Open Access
Massive Upper Body and Cervicofacial Subcutaneous Emphysema Following Robotic Myomectomy
Subcutaneous emphysema is defined as the unintentional introduction of air or carbon dioxide in the subcutaneous tissues. The use of robotic surgical techniques has greatly expanded over the past decade specifically to treat intraperitoneal pathology. In general, advantages of these minimally invasive procedures are reported to decrease operating time, patient morbidity, and shorten hospital stay providing a safe alternative to traditional surgery. However, as with any surgery, potential complications may occur. We describe an unusual case of massive subcutaneous emphysema involving the upper body and cervicofacial region, with bilateral pneumothoraces following robotic intraperitoneal surgery. Written authorization was obtained from the patient.
Surgical subcutaneous emphysema (SE) is a rare complication of laparoscopic and/or robotic surgery in which carbon dioxide (CO2) intended for abdominal insufflation spreads within the surrounding subcutaneous tissues leading to diffuse swelling and crepitus on palpation, with the potential for further extension along the fascial planes [1–5].
The overall incidence of subcutaneous emphysema following robotic assisted laparoscopic surgery is approximately 0.3%–3%. The potential risk is greater in elderly patients, with lengthy laparoscopic and robotic surgeries with more than five entry ports, and with the use of high CO2 insufflation pressures (15–20 mmHg) [6, 7]. The severity of SE following robotic-assisted laparoscopic surgery can be described as “mild” with crepitus at trocar insertion sites, “moderate” with crepitus extending to the abdomen and thighs, and “massive” with crepitus and swelling extending to the chest, neck, face, and extremities. Massive iatrogenic SE can potentially have life-threatening effects including hypercarbia, pneumothorax, and pneumomediastinum [1–7].
We report an unusual case of massive SE complicated with bilateral pneumothoraces related to robotic surgery with intraoperative vital signs maintained within normal limits and with the absence of a characteristic rise in end-tidal (et) CO2. SE particularly affected the cervicofacial region, despite the patient being in steep Trendelenburg position. Written authorization was obtained from the patient.
2. Case Presentation
A healthy 39-year-old female with no past medical or surgical history underwent robotic-assisted laparoscopic myectomy surgery for the presence of fibroids. Standard ASA monitors were applied, and general anesthesia was induced.
Pneumoperitoneum was created by CO2 insufflation with the intra-abdominal pressure maintained in the range of 12–15 mmHg. Intraoperatively, hemodynamic parameters, etCO2 and peak inspiratory pressure remained within normal limits. Maximum etCO2 noticed during this period was 42 mmHg and normalized by increasing minute volume of ventilation. Four hours after induction, the patient was noted to have developed marked swelling in the chest, neck, and face, particularly in the periorbital region (Figure 1). Palpation revealed skin crepitus extending from the operative site into the trunk, chest, neck, and face. Skin crepitus was particularly noticeable on the upper face involving the eyelids. The caudal extent of SE could not be appreciated due to patient positioning under the robotic surgery apparatus. Ventilatory parameters remained within normal limits at the time the SE was appreciated. The surgical team was notified and the SE was managed by lowering the peritoneal insufflation pressure, ongoing use of mechanical hyperventilation, and starting supportive measures, such as massaging the patient body, without any additional complications. At the end of the six-hour surgery, the pneumoperitoneum was deflated and upper body and facial swelling showed some instantaneous improvement. Prior to extubation, direct laryngoscopy was performed to exclude the presence of pharyngeal emphysema and laryngeal edema, which may accompany SE of the upper body leading to airway obstruction. The patient was extubated after a negative cuff-leak test ruled out airway compression by neck emphysema. A chest X-ray was taken in the post anesthesia care unit (PACU) and showed small bilateral pneumothoraces with diffuse SE (Figure 2).
The patient remained stable in the PACU and was transferred to the surgical intensive care unit (SICU) step-down unit. The patient’s pneumothoraces worsened on post-operative day (POD) 1; however the patient’s respiratory and hemodynamic parameters remained stable and were managed conservatively. This involved bed rest, medications to control pain, and 4 L of supplemental oxygen flow by Adult Oxygen Mask (AirLife™, CareFusion, CA, USA), which has facilitated absorption of the subcutaneous CO2 and/or air.
On POD 2, there was significant improvement in both the bilateral pneumothoraces as well as the SE, and the patient was transferred to a telemetry unit. In the SICU, the patient complained of severe pain throughout the whole body, which was treated by IV Dilaudid (0.2 mg IV Q15 min PRN, receiving the total of 2.4 mg over 24 h). On POD 3, the patient continued to demonstrate overall improvement in her condition, with minimal evidence of residual SE and crepitus. The patient was discharged home in stable condition with no further complications or complaints.
Robotic laparoscopic surgery is associated with lower perioperative morbidity and mortality and is used with increasing frequency for the treatment of a variety of intra-abdominal conditions previously treated with open or standard laparoscopic surgical techniques. The main advantages of robotic surgery include a significantly shorter overall recovery time and hospital stay. There is also significantly less need for analgesia use as there is no muscle splinting. On the other hand, although the operative times of robotic laparoscopic surgeries are generally shorter, they may be longer occasionally, especially in complex cases and/or if the operator is inexperienced when compared with open surgeries—as it was in our case [1, 5]. Insufflation of the abdominal cavity with CO2 decreases venous return to the heart, reduces cardiac output and index, causes a marked reduction in functional residual capacity, increases peak airway pressure, increases ventilation perfusion mismatch, and leads to increased alveolar/arterial oxygen (O2) gradient. Insufflated CO2 used to create a pneumoperitoneum is absorbed from the tissues into the blood, crossing the alveolar membrane, to be expelled as CO2. As a result, an increase in minute ventilation of approximately 25% is needed to maintain eucarbia [3, 5, 8, 9].
One of the rare but potentially serious complications of robotic-assisted laparoscopic surgery is SE. It usually develops due to dissection around the trocar sites after repeated attempts to insert the port or at time of port removal secondary to high insufflation pressures. In these cases, CO2 can diffuse outside intraperitoneal and extraperitoneal cavities causing subcutaneous emphysema, pneumothorax, pneumomediastinum, pharyngeal emphysema, and/or CO2 embolism [1, 2, 5]. Subsequent hypercarbia may lead to dysrhythmias while PaCO2 above 55 mmHg can result in systolic hypertension, increased central venous pressure, tachycardia, decreased peripheral vascular resistance, and eventually leading to respiratory acidosis. In the unanesthetized patient, respiratory compensation takes place in the form of an immediate increase in ventilation and an increase in the plasma concentration of bicarbonate produced by hydration of O2 [1, 5, 8, 9].
The anesthetized patient, in contrast to the awake patient, is incapable of mounting a hyperventilatory response, and in the absence of adequate compensation, the serum pH can fall below 7.0 subsequently leading to cardiac dysrhythmias and depression of the central nervous system. Ensuring hypercarbia following peritoneal insufflation requires compensatory ventilatory adjustments. If etCO2 continues to increase, other possibilities should be ruled out. A continued rise in etCO2 despite the increase in the maximal voluntary ventilation (MVV) is a worrisome sign for SE and justifies temporarily ceasing insufflation until etCO2 returns to normal. Differences in airway pressures and increased etCO2 are the earliest findings of SE. Increase of CO2 diffusion in SE usually causes hypercapnea and respiratory acidosis [1, 5, 8–10]. In our case, etCO2 increase was absent although significant swelling of the upper body and cervicofacial region was noticeable. However, the emphysema was not detected early due to failure to examine and palpate the chest wall and neck of the patient, assuming that some degree of dependent edema is expected in surgeries of this type. Therefore, iatrogenic SE should be included in the differential diagnosis with conditions that produce increased volume of the affected areas including hematoma, allergic reaction, angioedema, or cellulitis [1, 5, 11].
Cervicofacial and periorbital SE are usually complications of massive SE in laparoscopic surgeries or complications of maxillofacial and dental procedures [5, 9, 11]. Although periorbital SE is usually benign with spontaneous resolution, it can cause ischemic optic neuritis and central retinal artery occlusion leading to visual loss. When periorbital SE shows signs of pressure effects like restricted ocular motility, sluggish pupillary reaction, disc edema or decreased visual acuity, trapped CO2 should be drained by needle insertion or lateral canthotomy and/or cantholysis should be performed [1, 5, 11]. For anesthesiologists, it is import to quickly identify cervicofacial SE during the surgery and to then remove or loosen tape for eye protection to alleviate pressure effect on the eye globe .
In most cases, there are no specific interventions for SE as it usually resolves after peritoneal desufflation. In the absence of spontaneous resolution more invasive interventions may be warranted. Those interventions include insertion of a subcutaneous catheter or microdrainage with fenestrated catheters and compressive massage. They can be combined with the elective mechanical ventilation patient until resolution of the respiratory acidosis, hypercarbia, and SE [1, 5, 10]. In our case SE persisted for 3 days after surgery with minimal presence upon hospital discharge. The spread of CO2 from the abdominal wall to the chest wall, extending to the face, may lead to spread of CO2 to pass through the mediastinum or thorax, resulting in a pseudomediastinum or pneumothorax, as it did in our case. A chest X-ray should be performed to rule out the passage of CO2 into the mediastinum or thorax [1, 5, 6, 10]. In addition, arterial blood gases should be drawn to evaluate the extent of the hypercarbia. Other postoperative problems include facial swelling that may temporarily impair vision and pharyngeal swelling that may cause airway compromise. An endotracheal cuff leak test should be performed prior to extubation in these cases [1, 5, 6].
The presented case illustrates the importance of frequent palpation of chest wall under the surgical drapes when the patient is having robotic-assisted laparoscopic surgery even if ventilatory parameters and etCO2 are within normal limits [1, 5, 10].
Conflicts of Interest
The authors declare that they have no conflicts of interest.
- H. Celik, A. Cremins, K. A. Jones, and O. Harmanli, “Massive subcutaneous emphysema in robotic sarcrocolpopexy,” Journal of the Society of Laparoendoscopic Surgeons, vol. 17, no. 2, pp. 245–248, 2013.
- S. B. Kalhan, J. A. Reancy, and R. L. Collins, “Pneumomediastinum and subcutaneous emphysema during laparoscopy,” Cleveland Clinical Journal of Medicine, vol. 57, no. 7, pp. 639–642, 1990.
- S. Karaman, T. Akarsu, M. Bilgi, and V. Firat, “Subcutaneous emphysema and hypercarbia during diagnostic gynecologic laparoscopy: a case report,” Ege Journal of Medicine, vol. 44, no. 3, pp. 191–194, 2005.
- V. Khandelwal, P. Agrawal, D. Agrawal, and P. A. Nayak, “Subcutaneous emphysema of periorbital region after stainless steel crown preparation in a young child,” BMJ Case Reports, vol. 2013, no. 22(1), pp. bcr2013009952–bcr2013009952, 2013.
- C. E. Mullet, J. P. Viale, P. E. Sagnard et al., “Pulmonary CO2 elimination during surgical procedures using intra- or extraperitoneal CO2 insuffalation,” Anesthesia & Analgesia, vol. 76, no. 3, pp. 622–626, 1993.
- C. M. Murdock, A. J. Wolff, and T. Van Geem, “Risk factors for hypercarbia, subcutaneous emphysema, pneumothorax, and pneumomediastinum during laparoscopy,” Obstetrics and Gynecology, vol. 95, no. 5, pp. 704–709, 2000.
- V. R. Saggar, A. Singhal, K. Singh, B. Sharma, and R. Sarangi, “Factors influencing development of subcutaneous carbon dioxide emphysema in laparoscopic totally extraperitoneal inguinal hernia repair,” Journal of Laparoendoscopic & Advance Surgical Techniques, vol. 18, no. 2, pp. 213–216, 2008.
- A. Santana, R. S. Crausman, and H. G. Dubin, “Late onset of subcutaneous emphysema and hypercarbia following laparoscopic cholecystectomy,” Chest, vol. 115, no. 5, pp. 1468–1471, 1999.
- R. Srinivas, N. Singh, R. Agarwal, and A. N. Aggarwal, “Management of extensive subcutaneous emphysema and pneumomediastinum by microdrainage: time for re-think?” Singapore Medical Journal, vol. 48, no. 12, pp. e323–e326, 2007.
- J. S. Wolf Jr., R. V. Clayman, T. G. Monk, B. L. McClennan, and E. M. McDougall, “Carbon dioxide absorption during laparoscopic pelvic operation,” Journal of the American Collge of Surgeons, vol. 180, no. 5, pp. 555–560, 1995.
- J. B. Worrell and D. T. Cleary, “Massive subcutaneous emphysema and hypercarbia: complications of carbon dioxide absorption during extraperitoneal and intraperitoneal laparoscopic surgery-case studies,” AANA Journal, vol. 70, no. 6, pp. 456–461, 2002.
Copyright © 2019 Joseph Capone et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.